AMI Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-77,696
Closed -$23.4M 71
2018
Q4
$23.4M Sell
77,696
-5,346
-6% -$1.71M 1.93% 22
2018
Q3
$29.3M Sell
83,042
-1,433
-2% -$493K 2% 23
2018
Q2
$24.5M Sell
84,475
-2,361
-3% -$664K 1.75% 25
2018
Q1
$23.8M Sell
86,836
-1,781
-2% -$553K 1.7% 26
2017
Q4
$28.2M Sell
88,617
-3,457
-4% -$1.11M 1.95% 20
2017
Q3
$28.8M Sell
92,074
-821
-0.9% -$243K 2.04% 21
2017
Q2
$25.2M Sell
92,895
-1,668
-2% -$441K 1.8% 22
2017
Q1
$25.9M Sell
94,563
-781
-0.8% -$221K 1.95% 21
2016
Q4
$27M Sell
95,344
-8,233
-8% -$2.44M 2% 18
2016
Q3
$32.4M Sell
103,577
-1,656
-2% -$490K 2.23% 14
2016
Q2
$25.4M Sell
105,233
-3,264
-3% -$860K 1.77% 23
2016
Q1
$28.2M Buy
108,497
+21,618
+25% +$5.71M 1.94% 23
2015
Q4
$26.6M Sell
86,879
-18,545
-18% -$5.33M 1.85% 25
2015
Q3
$30.8M Buy
105,424
+7,697
+8% +$2.54M 2.35% 16
2015
Q2
$39.5M Buy
97,727
+5,052
+5% +$2.03M 2.94% 9
2015
Q1
$39.1M Buy
+92,675
New +$36.5M 3.04% 5

Other funds holding BIIB

AMI Asset Management's BIIB Position: Q1 2019 in Review

AMI Asset Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 77,696 shares — an estimated $23.4M sold.

AMI Asset Management first reported a position in BIIB in Q1 2015 and held it in 16 quarters. The position peaked at $39.5M in Q2 2015. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • AMI Asset Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • AMI Asset Management sold 77,696 Biogen shares in Q1 2019, an estimated $23.4M.
  • AMI Asset Management first reported a position in Biogen in Q1 2015 and held it in 16 quarters.
  • AMI Asset Management's Biogen position peaked at $39.5M in Q2 2015.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on AMI Asset Management's 13F filing for Q1 2019, filed 25 Apr 2019.